MICROINJECTION STUDIES ON PROTEIN DEGRADATION
蛋白质降解的微注射研究
基本信息
- 批准号:3274574
- 负责人:
- 金额:$ 22.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1980
- 资助国家:美国
- 起止时间:1980-01-01 至 1994-12-31
- 项目状态:已结题
- 来源:
- 关键词:HeLa cells albumins arginine autophagy biological signal transduction cell bank /registry cell growth regulation cell nucleus cell type chemical conjugate chemical stability conformation cysteine cytoplasm deficient growth media dyes endopeptidases enzyme mechanism enzyme substrate analog globin immunochemistry laboratory mouse laboratory rabbit lysozyme microinjections oxyhemoglobin phenylhydrazines proline protease inhibitor protein folding protein metabolism protein reconstitution protein structure proteolysis radiotracer stress proteins temperature sensitive mutant thermostability tissue /cell culture transport proteins ubiquitin western blottings
项目摘要
The long term objective of this proposal os to elucidate the mechanisms by
which cells selectively degrade their intracellular proteins and to
discover the features of protein that promote their catabolism. Two cell
systems are available in which it is possible to eliminate either proline
endopeptidase or ubiquitin (Ub) conjugation. Individual, radiolabeled
proteins will be injected into each cell line to determine which proteins
are substrates for these pathways. This procedure has already revealed
that ubiquitin and bovine serum albumin ar stabilized in cells lacking
proline endopeptidase and that oxidized hemoglobin is stabilized in ts85
mouse cells which contain a labile Ub-activating enzyme. The half-lives of
a series of temperature-sensitive T4 lysozymes will also be measured to
test the hypothesis that thermodynamic stability correlates with metabolic
stability. Surprisingly, T4 lysozyme is degraded very rapidly in HeLa
cells, and we will determine whether surface cysteines or arginine-arginine
pairs are responsible for its short life. In addition, specific proteins
will be targeted to the nucleus to discover whether their degradation rates
are affected by mislocalization. Finally, ubiquitin will be injected into
ts85 mouse cells or HeLa cells and several aspects of Ub metabolism will be
measured, including Ub's role in autophagy and release of injected
proteins, as well as the subcellular location of Ub conjugates before and
after heat-shock.
本提案的长期目标是通过以下方式阐明机制:
这些细胞选择性地降解它们的细胞内蛋白质,
发现蛋白质的特征,促进他们的catalysis。 两种细胞
可获得这样的系统,其中可以消除脯氨酸或脯氨酸,
内肽酶或泛素(Ub)缀合。 单个放射性标记
将蛋白质注射到每个细胞系中以确定哪些蛋白质
是这些途径的底物。 这个过程已经揭示了
泛素和牛血清白蛋白在缺乏
脯氨酸内肽酶和氧化血红蛋白在TS 85中稳定
含有不稳定的Ub激活酶的小鼠细胞。 的半衰期
还将测量一系列温度敏感的T4溶菌酶,
测试热力学稳定性与代谢相关的假设
稳定 令人惊讶的是,T4溶菌酶在HeLa中降解非常迅速
细胞,我们将确定是否表面半胱氨酸或精氨酸精氨酸
对是它寿命短的原因 此外,特定的蛋白质
将瞄准原子核,以发现它们的降解率
都受到定位错误的影响 最后,将泛素注入
ts85小鼠细胞或HeLa细胞和Ub代谢的几个方面将被
测量,包括Ub在自噬和释放注射的
蛋白质,以及Ub缀合物在之前和之后的亚细胞位置。
热休克后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN C RECHSTEINER其他文献
MARTIN C RECHSTEINER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN C RECHSTEINER', 18)}}的其他基金
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
- 批准号:
6826106 - 财政年份:2004
- 资助金额:
$ 22.48万 - 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
- 批准号:
7056150 - 财政年份:2004
- 资助金额:
$ 22.48万 - 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
- 批准号:
6898835 - 财政年份:2004
- 资助金额:
$ 22.48万 - 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
- 批准号:
7216180 - 财政年份:2004
- 资助金额:
$ 22.48万 - 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
- 批准号:
7391680 - 财政年份:2004
- 资助金额:
$ 22.48万 - 项目类别:
PROPERTIES OF AN ATP/UBIQUITIN-DEPENDENT PROTEASE
ATP/泛素依赖性蛋白酶的特性
- 批准号:
6329672 - 财政年份:1986
- 资助金额:
$ 22.48万 - 项目类别:
相似海外基金
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10685312 - 财政年份:2021
- 资助金额:
$ 22.48万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10490872 - 财政年份:2021
- 资助金额:
$ 22.48万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10345963 - 财政年份:2021
- 资助金额:
$ 22.48万 - 项目类别:
Development of Highly Functionalized Serum Albumins as Boron Delivery Carries to Tumor for Neutron Capture Therapy
开发高功能化血清白蛋白作为硼输送至肿瘤以进行中子捕获治疗
- 批准号:
17H02202 - 财政年份:2017
- 资助金额:
$ 22.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on Asymmetric Nitroaldol Reaction using mutant albumins
突变体白蛋白不对称硝醛醇反应的研究
- 批准号:
16K05706 - 财政年份:2016
- 资助金额:
$ 22.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SPIN LABELING STUDIES OF NORMAL RECOMBINANT & MUTANT HUMAN SERUM ALBUMINS
正常重组的旋转标记研究
- 批准号:
6118869 - 财政年份:1999
- 资助金额:
$ 22.48万 - 项目类别:
COPPER BINDING OF COMMERCIAL, NORMAL RECOMBINANT, & MUTANT HUMAN SERUM ALBUMINS
商业、正常重组的铜结合,
- 批准号:
6118864 - 财政年份:1999
- 资助金额:
$ 22.48万 - 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia in Fowl
家禽双清蛋白血症血清白蛋白的结构与代谢特征
- 批准号:
67B6472 - 财政年份:1967
- 资助金额:
$ 22.48万 - 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia
双清蛋白血症血清白蛋白的结构和代谢特征
- 批准号:
65B3344 - 财政年份:1965
- 资助金额:
$ 22.48万 - 项目类别:














{{item.name}}会员




